Chemical Compound

5-azacytidine

CAS Registry Number 320-67-2
Back to search Request a Quote
5-azacytidine chemical structure
Primary Record

5-azacytidine

In stock
3,401 g
Purity
98.8 %
CAS
320-67-2

Compound Identifiers & Properties

CAS
320-67-2
PubChem CID
9444
SMILES
C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
Canonical SMILES
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1

Names & Synonyms

  • 5-azacytidine
  • Azacitidine
  • Azacytidine
  • Ladakamycin
  • Vidaza
  • Mylosar
  • 320-67-2
  • Azacitidina
  • 5-azacitidine
  • Azacitidinum
  • Onureg
  • 5 Azacytidine
  • mylo sar
  • Ledakamycin
  • azacitidine for
  • Antibiotic U 18496
  • Azacitidinum [INN-Latin]
  • Azacytidine, 5-
  • Azacitidina [INN-Spanish]
  • 5'-Azacytidine
  • 5-Azacytidine?
  • 5-AZCR
  • Vidaza (TN)
  • 5 AZC
  • 5-AZAC
  • 5-AzadCyD
  • 5AzaC
  • 5-aza-CR
  • Azacitidine [USAN:INN]
  • FAZARABINE
  • 5-Aza-xylo-cytidine
  • Azacitidine (Vidaza)
  • C8H12N4O5
  • Vidaz (TN)
  • Azacitidine, 5-AzaC
  • 5AzC
  • CCRIS 60
  • 5-Azacytosine riboside
  • NSC-102816
  • 5-AC
  • Spectrum_001262
  • RefChem:57658
  • DTXSID9020116
  • Antibiotic U-18496
  • MFCD00006539
  • AZACITIDINE [MI]
  • Spectrum2_000786
  • Spectrum3_001509
  • Spectrum4_000922
  • Spectrum5_001166
  • AZACITIDINE [INN]
  • AZACITIDINE [JAN]
  • Azacytidine/5-Azacytidine
  • CHEBI:2038
  • M801H13NRU
  • UNII-M801H13NRU
  • NSC 102816
  • 5-Azacytidine (Standard)
  • NCI-C01569
  • AZACITIDINE [HSDB]
  • AZACITIDINE [IARC]
  • AZACITIDINE [USAN]
  • cc-486
  • D09FAZ
  • DTXCID10116
  • Epitope ID:613415
  • MolMap_000062
  • AZACITIDINE [VANDF]
  • HSDB 6879
  • AC1L1T1Y
  • Azacitidine (JAN/USAN/INN)
  • Azacitidine [USAN:INN:BAN]
  • SCHEMBL3741
  • NMUSYJAQQFHJEW-KVTDHHQDSA-N
  • AZACITIDINE [MART.]
  • CHEMBL1489
  • Azacitidine (5-Azacytidine)
  • Lopac0_000035
  • NSC102816
  • U-18496
  • AZACITIDINE [USP-RS]
  • AZACITIDINE [WHO-DD]
  • BSPBio_003157
  • KBioGR_001444
  • KBioGR_002556
  • KBioSS_001742
  • KBioSS_002565
  • AZACITIDINE AZACITIDINE
  • KSC222S1T
  • MLS001333121
  • MLS001333122
  • MLS002153249
  • MLS002548894
  • Pharmion Brand of Azacitidine
  • DivK1c_000125
  • SCHEMBL433074
  • SPECTRUM1502111
  • EINECS 206-280-2
  • SPBio_000892
  • AZACITIDINE [EMA EPAR]
  • Azacitidine;5-AzaC;Ladakamycin
  • GTPL6796
  • NS-17
  • orb1308921
  • Jsp005945
  • wr 183027
  • BCBcMAP01_000083
  • CTK1C2919
  • ERK5-1G06
  • HMS500G07
  • KBio1_000125
  • KBio2_001742
  • KBio2_002556
  • KBio2_004310
  • KBio2_005124
  • KBio2_006878
  • KBio2_007692
  • KBio3_002657
  • KBio3_003034
  • NMUSYJAQQFHJEW-KVTDHHQDSA-
  • AZACITIDINE [ORANGE BOOK]
  • BRN 0620461
  • CID9444
  • L01BC07
  • WR-183027
  • cMAP_000082
  • NINDS_000125
  • 4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one
  • GLXC-07091
  • HMS1921J22
  • HMS2092D08
  • HMS2231F15
  • HMS3259D19
  • HMS3260G11
  • Pharmakon1600-01502111
  • 4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one
  • 5-Azacytidine, 99% - 1G 1g
  • Amino-beta-D-ribofuranosyltriazinone
  • CID:9444
  • ZINC3861768
  • 5-Azacytidine, >=98% (HPLC)
  • Tox21_111032
  • Tox21_302985
  • Tox21_500035
  • U 18496
  • ABP001093
  • ANW-27256
  • BDBM50424715
  • C8-H12-N4-O5
  • CCG-39046
  • EBC-11024
  • EBD145507
  • HB1374
  • HY-10586R
  • NCGC00090851-04
  • NSC758186
  • s1782
  • SBB066305
  • U-18,496
  • Onureg (CC-486; oral azacitidine)
  • AKOS015896938
  • Tox21_111032_1
  • ACN-038132
  • AM83944
  • CS-1287
  • DB00928
  • J1.523G
  • LP00035
  • LS-1189
  • NA02947
  • NC00672
  • NSC-758186
  • RP28647
  • RTR-013523
  • IDI1_000125
  • NSC-103-627
  • 5-azacytidine;Mylosar;Ladakamycin;Vidaza
  • NCGC00090851-01
  • NCGC00090851-02
  • NCGC00090851-03
  • NCGC00090851-05
  • NCGC00090851-06
  • NCGC00090851-07
  • NCGC00090851-08
  • NCGC00090851-10
  • NCGC00090851-14
  • NCGC00090851-18
  • NCGC00090851-22
  • NCGC00178234-01
  • NCGC00256541-01
  • NCGC00260720-01
  • AS-13697
  • CAS-320-67-2
  • CPD000857239
  • HY-10586
  • SAM002264595
  • SC-09078
  • SID:53790547
  • SMR000857239
  • SRI-10756_10
  • SRI-10756_12
  • ST056940
  • SY023613
  • A 2385
  • AB2000290
  • DB-006955
  • SL-000003
  • TR-013523
  • 4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one
  • A1907
  • EU-0100035
  • NS00008631
  • ST24044344
  • TL80073599
  • 1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-
  • 2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one
  • s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-
  • A10105
  • C11262
  • D03021
  • EN300-118700
  • F10504
  • J10124
  • 33795-EP2275420A1
  • 33795-EP2295055A2
  • 33795-EP2295416A2
  • 33795-EP2298748A2
  • 33795-EP2298764A1
  • 33795-EP2298765A1
  • 33795-EP2305642A2
  • 33795-EP2311453A1
  • 33795-EP2311840A1
  • 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one
  • 124679-EP2270008A1
  • 124679-EP2292617A1
  • 124679-EP2295426A1
  • 124679-EP2295427A1
  • 320A672
  • 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
  • 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
  • A821115
  • D001374
  • F492447
  • Q416451
  • SR-01000075662
  • 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one
  • 4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one
  • pyrimidine antimetabolite: inhibits nucleic acid replication
  • SR-01000075662-1
  • SR-01000075662-3
  • SR-01000075662-7
  • 4-Amino-1-beta-D-ribofuranosyl-D-triazin-2(1H)-one
  • BRD-K03406345-001-02-1
  • BRD-K03406345-001-21-1
  • BRD-K03406345-001-27-8
  • 1,3,5-Triazin-2(1H)-one, 4-amino-1-.beta.-D-ribofuranosyl-
  • 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one
  • 4-Amino-1-.beta.-D-ribofuranosyl-s-triazin-2(1H)-one
  • 4-Amino-1-?-D-ribofuranosyl-1,3,5-triazin-2(1H)-one
  • 5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine
  • Z1515383340
  • 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazine-2(1H)-one
  • S-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-(8CI)
  • 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz
  • Azacitidine, United States Pharmacopeia (USP) Reference Standard
  • 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one; Ladakamycin
  • 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one
  • Azacitidine, Pharmaceutical Secondary Standard; Certified Reference Material
  • 1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-amino-1,3,5-tri azin-2-one
  • 12679-86-6
  • 1401238-97-8
  • 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one
  • 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydro-1,3,5-triazin-2-one
  • 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,3,5-triazin-2-one
  • 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-
  • 5-AC; 5-AZC; 5-AZCR; 5-AzaC; 5-Azacytidine; Antibiotic U 18496; Azacitidine; Azacytidine; Ladakamycin; Ledakamycin; Mylosar; NSC 102816; NSC 103-627; U 18496; Vidaza; WR 183027; 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one; s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI)
  • 5-Azacytidine, Hybri-Max(TM), gamma-irradiated, lyophilized powder, BioXtra, suitable for hybridoma
  • 5AE
  • 931-86-2
  • InChI=1/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
  • one